Otezla 10 mg, 20 mg film-coated tablets

Licence status
Authorised: 15/01/2015
Active substances
Apremilast, Apremilast
Dosage Form
Film-coated tablet
Licence number
EU/1/14/981/004
Licence holder
Amgen Europe B.V.,

Product documents

Licence information

ATC code
L04AA32 apremilast
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
15/01/2015